Dynavax Pharma (DVAX): Bathi resik saben saham sajrone 12 wulan pungkasan

Simbol lan logo merek Dynavax Technologies (DVAX)

Dynavax Technologies (DVAX) leads in the development of advanced vaccines and CpG 1018 platforms, investing in the fight against liver infections. Fundamental net income per share TTM demonstrates yield dynamics, with the indicator fixed at -0.38. An impeccable brand image is confirmed by physician trust in hepatitis B medications. A stable cash flow is ensured by strong demand for the flagship product.

DVAX (Dynavax) riwayat Bathi resik saben siji saham sajrone rolas wulan pungkasan saka 04.07.2022 nganti 21.02.2026

Rincian metrik keuangan lan pasar dynavax.com (DVAX)

- rega saham lan target rega konsensus:
Rega saham Dynavax Corp|DVAX - Target median analis
- data kapitalisasi bursa:
Biji pasar Dynavax Corp|DVAX - Nilai Total Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Buku saben Saham Dynavax|DVAX - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku dynavax.com|DVAX - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Dynavax Technologies|DVAX - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Dynavax Technologies Corp|DVAX - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Dynavax|DVAX - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Dynavax|Indikator likuiditas cepet dynavax.com
- indikator pendapatan resik lan kelipatan nilai:
DVAX - Bathi resik perusahaan|Proyeksi bathi mangsa ngarep Dynavax Technologies|DVAX - Pangali P/E|Prakiraan rega marang bathi Dynavax Pharma|DVAX - Rasio P/E diaturake wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Dynavax Pharma|DVAX - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Dynavax|DVAX - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan dynavax.com|DVAX - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Dynavax Technologies
- data pendapatan lan penerimaan dodolan:
DVAX - Dodolan perusahaan|Prakiraan volume dodolan Dynavax Pharma|DVAX - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang prakiraan pendapatan Dynavax|DVAX - Wutah dodolan YoY sajrone 12 wulan kepungkur
Analisis dhasar perusahaan:DVAX - Dynavax Corp
Produk sing diprodhuksi Dynavax Technologies

The indicator calculates the ratio of net income to the total number of shares over a rolling year, measuring the actual efficiency of capital generation per share. Steady growth in the rolling earnings per share history confirms the transition of Dynavax Technologies (DVAX) from startup status to that of a reliable player, converting high confidence in hepatitis B vaccines into a sustainable financial result.

Pesaing langsung

Arrowhead Pharma - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone patang kuartal pungkasan Mirum Pharma MIRM|ABUS (Arbutus) - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan Inventiva Corp (IVA)|GYRE (Gyre Therapeutics Inc) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan assemblybio.com ASMB|Bathi saben saham sajrone rolas wulan pungkasan Galectin Therapeutics, Inc. (GALT)|GNFT (GENFIT) - Bathi saben saham sajroning taun lumaku|Bathi resik saben saham (EPS TTM) DRRX (durect.com)|Bathi resik saben saham (EPS TTM) Aligos Therapeutics ALGS|BioVie Inc - Bathi resik saben saham (EPS TTM)|GLMD - Bathi resik saben saham (EPS TTM)|NDRA: Bathi resik saben saham (EPS TTM)|Bathi saben siji saham sajrone 12 wulan pungkasan HEPA (Hepion Pharmaceuticals Inc.)